Free Trial

The Allstate Co. (NYSE:ALL) Short Interest Up 17.3% in November

Allstate logo with Finance background

The Allstate Co. (NYSE:ALL - Get Free Report) saw a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 2,370,000 shares, a growth of 17.3% from the November 15th total of 2,020,000 shares. Approximately 0.9% of the company's stock are sold short. Based on an average daily volume of 1,490,000 shares, the short-interest ratio is currently 1.6 days.

Wall Street Analysts Forecast Growth

ALL has been the subject of a number of research reports. Evercore ISI boosted their price target on shares of Allstate from $191.00 to $195.00 and gave the company an "in-line" rating in a research report on Wednesday, October 9th. The Goldman Sachs Group boosted their target price on Allstate from $209.00 to $230.00 and gave the company a "buy" rating in a report on Friday, November 15th. TD Cowen raised their price target on Allstate from $193.00 to $224.00 and gave the stock a "buy" rating in a research note on Tuesday, September 3rd. StockNews.com cut Allstate from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, August 21st. Finally, Piper Sandler raised their target price on shares of Allstate from $206.00 to $244.00 and gave the stock an "overweight" rating in a research report on Tuesday, November 26th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Allstate presently has a consensus rating of "Moderate Buy" and an average target price of $217.19.

Get Our Latest Analysis on Allstate

Insider Buying and Selling at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the company's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 57.06 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 1.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ALL. State Street Corp grew its holdings in Allstate by 1.1% in the third quarter. State Street Corp now owns 11,496,306 shares of the insurance provider's stock valued at $2,190,758,000 after purchasing an additional 126,922 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Allstate by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,228,581 shares of the insurance provider's stock worth $1,178,164,000 after buying an additional 74,537 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Allstate by 18.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock valued at $569,114,000 after acquiring an additional 472,040 shares during the last quarter. Raymond James & Associates grew its position in shares of Allstate by 10.6% in the third quarter. Raymond James & Associates now owns 1,517,800 shares of the insurance provider's stock valued at $287,851,000 after purchasing an additional 145,986 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Allstate by 3.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,437,688 shares of the insurance provider's stock worth $229,545,000 after buying an additional 47,038 shares in the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Stock Performance

NYSE ALL traded down $1.24 during trading hours on Monday, hitting $195.02. 1,338,304 shares of the stock were exchanged, compared to its average volume of 1,549,459. Allstate has a 12-month low of $134.17 and a 12-month high of $209.88. The stock has a 50-day moving average of $194.95 and a 200 day moving average of $181.54. The company has a market cap of $51.64 billion, a price-to-earnings ratio of 12.73, a price-to-earnings-growth ratio of 1.70 and a beta of 0.50. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43.

Allstate (NYSE:ALL - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating the consensus estimate of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The business had revenue of $16.63 billion during the quarter, compared to analysts' expectations of $14.57 billion. During the same period last year, the firm earned $0.81 EPS. The company's quarterly revenue was up 14.7% compared to the same quarter last year. As a group, equities research analysts forecast that Allstate will post 16.26 earnings per share for the current year.

Allstate Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be paid a dividend of $0.92 per share. The ex-dividend date is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.89%. Allstate's dividend payout ratio (DPR) is presently 23.83%.

Allstate Company Profile

(Get Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

See Also

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines